tiprankstipranks
Advertisement
Advertisement
Ligand Pharma completes transformative XOMA royalty acquisition
PremiumCompany AnnouncementsLigand Pharma completes transformative XOMA royalty acquisition
8d ago
Agenus announces $340M private placement
Premium
The Fly
Agenus announces $340M private placement
10d ago
Ligand price target raised to $388 from $266 at BofA
Premium
The Fly
Ligand price target raised to $388 from $266 at BofA
14d ago
Ligand prices upsized $625M convertible senior note offering
PremiumThe FlyLigand prices upsized $625M convertible senior note offering
1M ago
Ligand files to sell $550M of convertible senior notes due 2031
Premium
The Fly
Ligand files to sell $550M of convertible senior notes due 2031
1M ago
Ligand Pharma Plans $550 Million Convertible Notes Offering
Premium
Company Announcements
Ligand Pharma Plans $550 Million Convertible Notes Offering
1M ago
Ligand Pharmaceuticals’ Earnings Call Signals Scaled Royalty Push
PremiumCompany AnnouncementsLigand Pharmaceuticals’ Earnings Call Signals Scaled Royalty Push
2M ago
Ligand reports Q1 adjusted EPS $1.63, consensus $1.80
Premium
The Fly
Ligand reports Q1 adjusted EPS $1.63, consensus $1.80
3M ago
Ligand backs FY26 adjusted EPS view $8.50-$9.50, consensus $9.21
Premium
The Fly
Ligand backs FY26 adjusted EPS view $8.50-$9.50, consensus $9.21
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100